Literature DB >> 11843832

Outcome for children after failed transplant for primary haemophagocytic lymphohistiocytosis.

K M Ardeshna1, J Hollifield, J M Chessells, P Veys, D K Webb.   

Abstract

Primary haemophagocytic lymphohistiocytosis is a rare disorder of childhood, which is usually fatal without allogeneic stem cell transplantation (SCT). For children who lack a matched family or closely matched unrelated donor, SCT using haploidentical parental stem cells has been used, but is associated with an increased risk of graft failure. The most appropriate subsequent management for those children who survive after graft rejection is currently unclear. We report the outcome for three such children. After a period of disease quiescence lasting 4 months to 8 years, disease recurrence and subsequent death occurred in each case. Accordingly, a second SCT is recommended.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11843832     DOI: 10.1046/j.1365-2141.2001.03177.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.

Authors:  Paul A Veys; Vasanta Nanduri; K Scott Baker; Wensheng He; Giuseppe Bandini; Andrea Biondi; Arnaud Dalissier; Jeffrey H Davis; Gretchen M Eames; R Maarten Egeler; Alexandra H Filipovich; Alain Fischer; Herbert Jürgens; Robert Krance; Edoardo Lanino; Wing H Leung; Susanne Matthes; Gérard Michel; Paul J Orchard; Anna Pieczonka; Olle Ringdén; Paul G Schlegel; Anne Sirvent; Kim Vettenranta; Mary Eapen
Journal:  Br J Haematol       Date:  2015-03-27       Impact factor: 6.998

Review 2.  Reduced-intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward.

Authors:  Rebecca A Marsh; Michael B Jordan; Alexandra H Filipovich
Journal:  Br J Haematol       Date:  2011-06-28       Impact factor: 6.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.